Abstract. The expression levels of microRNA-21 (miR-21) are increased in a number of types of solid tumors. However, the association between miR-21 expression and clinical features of patients with gastric carcinoma, and gastric cancer proliferation, invasion and migration remains to be elucidated. The present study investigated the effect of miR-21 on the clinical features, proliferation, invasion and migration of gastric cancer and the underlying mechanisms associated with Noxa. Reverse transcription quantitative polymerase chain reaction (RT-qPCR) was performed to detect the expression levels of miR-21 and Noxa in samples of gastric cancer tissue and matched, adjacent, non-tumor tissue. The association between miR-21 expression and the clinical features of patients with gastric carcinoma, as well as the correlation between the mRNA and protein expression levels of miR-21 and Noxa were analyzed. SGC-7901 gastric cancer cells were cultured in vitro and transfected with an miR-21 mimic. The effect of miR-21 upregulation on proliferation and the cell cycle was determined using the MTT assay and flow cytometry. In addition, migration and invasion of SGC-7901 cells were observed using the Transwell assay. The target gene of miR-21 was identified using bioinformatics software and a dual luciferase reporting system. The effect of miR-21 upregulation on Noxa expression levels in SGC-7901 cells was also analyzed by RT-qPCR and western blotting. Increased levels of miR-21 expression and decreased levels of Noxa expression were observed in gastric cancer tissue samples when compared with the adjacent non-tumor tissue samples. An increased miR-21 expression level was identified as a risk factor for advanced stage gastric cancer, lymph node metastasis and larger primary tumors. Furthermore, the overexpression of miR-21 inhibited Noxa expression levels in SGC-7901 cells. Therefore, high levels of miR-21 expression may induce gastric cancer migration and invasion via the downregulation of Noxa expression.
Introduction
Gastric cancer is a common type of gastrointestinal cancer worldwide (1) . In China, the incidence of gastric cancer is the highest of the digestive system neoplasms and second for all malignant tumors (2) . Recent studies have observed that there are ~500,000 diagnoses of gastric cancer in China every year, accounting for ~50% of diagnoses worldwide. Furthermore, stomach cancer results in 10% of cancer-associated mortalities (3) . Investigations into the association between microRNA (miR) and stomach cancer have increased. miRs are a class of non-coding RNA 18-21 nt in length. They are highly expressed in eukaryotic cells, and contribute to the regulation of cell growth, development and apoptosis (4, 5) . Numerous studies have shown that the occurrence and progression of tumors is accompanied by an abnormal change in miR expression levels (6, 7) . A number of studies have demonstrated increased expression levels of miR-21 in various solid tumors, for example, Volinia et al (8) observed that miR-21 was upregulated in breast and lung cancer, and was associated with a poor prognosis. However, the association between miR-21 expression and gastric cancer proliferation, invasion and migration has not been widely investigated, and the underlying mechanism of the potential target protein miR-21 remains to be elucidated. The present study aimed to validate the association between miR-21 and the clinical features of patients with gastric cancer, as well as the proliferation, invasion and migration of gastric cancer cells by analyzing samples of gastric cancer tissues and the results of in vitro cellular experiments. Bioinformatics and dual luciferase report analysis in the SGC-7901 gastric cancer cell line was performed in the current study and demonstrated that Noxa, a member of the B-cell lymphoma 2 (Bcl-2) family with pro-apoptotic effects (9-11) is the target gene of miR-21. (Table I ). The patients had not received preoperative chemotherapy or radiotherapy. The present study was approved by the ethics committee of the Fifth Affiliated Hospital of Zhengzhou University (Zhengzhou, China).
MicroRNA-21 expression is associated with the clinical features

Detection of miR-21 in tissue samples.
The miR was extracted and purified from cancer tissues and matched adjacent non-tumor tissues of the 40 patients using a paraffin-embedded tissue microRNA rapid extraction kit (Beijing Bioteke Biotechnology Co., Ltd., Beijing, China) according to the manufacturer's protocols. In brief, tissue samples were treated with dimethylbenzene to remove the paraffin and then guanidinium isothiocyanate was added for tissue lysis. Lysates were treated with chloroform and centrifuged at 12,000 x g for 15 min according to the manufacturer's instructions of the protein extract kit (Thermo Fisher Scientific, Inc., Waltham, MA, USA). miRNA products were purified using a silicon substrate membrane adsorption column from the extraction kit. Reverse transcription (RT) of miR into cDNA was performed using a One
Step PrimeScript miRNA cDNA Synthesis kit (Takara Biotechnology, Co., Ltd., Dalian, China) according to the manufacturer's protocols. For each sample, 2 µg miR was reverse transcribed in the reaction system, including miR reaction buffer mix (containing oligo-dt and RT primers miRNA) and PrimeScript ® RT enzyme mix (containing poly(A) polymerase and reverse transcriptase). For setting the RT -control, the same system was used, however, water was used to replace miR. The reaction conditions were as follows: 60 min poly(A) polymerase reaction and reverse transcription at 37˚C and 5 sec at 85˚C for inactivating the enzymes. The cDNA was amplified by RT quantitative polymerase chain reaction (qPCR) with the SYBR ® Premix Ex Taq™ II kit (Takara Biotechnology, Co., Ltd.) according to the manufacturer's protocols. The primers were as follows: Sense, 5'-GCC GCT AGC TTA TCA GAC TGA TGT-3' for miR-21; and sense, 5'-CTC GCT TCG GCA GCACA-3' for U6 snRNA, which was used to normalize the data. Sense, 5'-TTC GTG TTC AGC TCG CGTCC-3' and antisense, 5'-CTC GGT GTA GCC TTC TTGCC-3' for Noxa; and sense, 5'-ACC ACA GTC CAT GCC ATCAC-3' and antisense, 5'-TCC ACC ACC CTG TTG CTGTA-3' for GAPDH, which was used to normalize the data. The relative expression level of Noxa was expressed by 2 -ΔΔCq (for tumor tissue / non-tumor tissue). Total protein of the tissue sample was extracted by radioimmunoprecipitation assay (RIPA) lysis buffer (Thermo Fisher Scientific, Inc.) containing 1% protease inhibitor cocktail (500 µl/well; Thermo Fisher Scientific, Inc.). Electrophoresis was performed with 12% polyacrylamide gel (Applygen Technologies Inc., Beijing, China) at 100 V for 1.5 h and for each sample, 45 µg protein was loaded onto each lane. Following electrophoresis, the protein bands were transferred to a polyvinylidene fluoride membrane (Applygen Technologies, Inc.) with a 200-mA constant current for 1.5 h. The membranes were blocked for 1 h with 5% skimmed milk powder at room temperature prior to incubation with mouse monoclonal anti-human Noxa antibody (1:500; Santa Cruz Biotechnology, Inc., Dallas, TX, USA; cat. no. sc-398873) and mouse monoclonal anti-human β-actin antibody (1:1,000; Santa Cruz Biotechnology, Inc.; cat. no. sc-47778) at 4˚C overnight. The membranes were washed three times with phosphate-buffered saline with Tween-20 (Applygen Technologies, Inc.) to remove excess antibodies, and the horseradish peroxidase-labeled goat anti-mouse IgG (1:500; Santa Cruz Biotechnology, Inc; cat. no. sc-2005) secondary antibody was added and incubated for 2 h at room temperature. The membranes were washed to remove excess antibodies and color development of bands was visualized using an enhanced chemiluminescence color development kit (Applygen Technologies, Inc.), and the Noxa protein band intensity was analyzed using the BandScan system (Tanon 5200 Image Analysis System; Tanon Science & Technology Co., Ltd., Shanghai, China).
Culture of the SGC-7901 gastric cancer cell line.
The SGC-7901 human gastric cell line was purchased from the cell bank of the Shanghai Institute of Biochemistry and Cell Biology (Chinese Academy of Sciences, Shanghai, China). Dulbecco's modified Eagle's medium (DMEM; Thermo Fisher Scientific, Inc.) containing 10% fetal bovine serum (FBS; Thermo Fisher Scientific, Inc.) was used for cell culture and 0.25% trypsin (Thermo Fisher Scientific, Inc.) was used for cell digestion. Cells were cultured at 37˚C in 5% CO 2 for 24-48 h.
Upregulation of miR-21. miR-21 mimics were designed and synthesized by Shanghai GenePharma Co., Ltd. (Shanghai, China). SGC-7901 cells in the logarithmic growth phase were transfected with the miR-21 mimic and the miR-negative control (NC) using a Lipofectamine™ 2000 transfection kit (Thermo Fisher Scientific, Inc.). The transfection was conducted according to the manufacturer's protocol. Overexpression of miR-21 was verified using RT-qPCR 48 h following transfection.
Effect of miR-21 upregulation on SGC-7901 cell proliferation and the cell cycle.
The non-transfected (control), miR-21 mimic-transfected and miR-NC-transfected SGC-7901 cells were maintained in 96-well plates at a density of 1x10 4 /well for 6, 12, 24 or 48 h. MTT reagent (10 µl) was added to each well, and after 4 h, DMSO (100 µl) was added to each well. The optical density (OD) values at 490 nm were determined using a microplate reader (UV/Vis Absorbance Spectra; BMG Labtech, Ltd., Cary, NC, USA). For cell cycle analysis, transfected and non-transfected cells were fixed in cold 70% ethanol and stained with 50 µg/ml propidium iodide (Sigma-Aldrich, chamber. Following culture for 6 h, the cells that had remained in the upper chamber were removed, and the number of cells that had migrated or invaded the lower layer was estimated using Giemsa (Applygen Technologies, Inc.) staining.
Prediction and verification of miR-21 targets.
The target gene of miR-21 was predicted using the bioinformatics prediction software, PicTar (http://pictar.mdc-berlin.de/) and TargetScan5.0 (Whitehead Institute for Biomedical Research, Cambridge, MA, USA). Following integration of the results from the software, the candidate target genes were further confirmed by the dual luciferase reporting system. Shanghai Sangong Pharmaceutical Co., Ltd. (Shanghai, China) designed and constructed the luciferase reporter plasmid containing wild-type Noxa 3'-untranslated region (UTR) and mutant Noxa 3'-UTR, designated pMIR-Noxa-wild and pMIR-Noxa-mut, respectively. The SGC-7901 cells were divided into four groups as follows: miR-21 mimic + pMIR-Noxa-wild; miR-NC + pMIR-Noxa-wild; miR-21 mimic + pMIR-Noxa-mut;and miR-NC + pMIR-Noxa-wild. Following transfection, cells were cultivated in 96-well plates at a density of 1x10 4 /well and cultured for 48 h, prior to the addition of 100 µl lysis buffer (Applygen Technologies, Inc.) to each well. The supernatant was collected following lysis, and 10 µl of supernatant was added to the 40 µl firefly luciferase substrate and mixed evenly for 15 sec prior to determining the fluorescence intensity. The remaining supernatant was added to 40 µl Renilla luciferase substrate, and mixed evenly before determining the fluorescence intensity. The ratio of firefly to Renilla luciferase intensity was calculated to demonstrate the effect of miR-21 on the expression level of Noxa mRNA.
Effect of miR-21 overexpression on Noxa expression levels.
The total RNA of non-transfected, miR-21 mimic-transfected and miR-NC-transfected SGC-7901 cells was extracted using TRIzol ® . The RT of miR into cDNA was performed using the GoScript Reverse Transcription kit [Promega (Beijing) Biotech Co., Ltd.] according to the manufacturer's protocols. Fluorescent RT-qPCR was implemented using a GoTaq ® qPCR kit according to the manufacturer's protocols. The sequence of the primers for Noxa was as described above. The total protein in the cells was extracted using RIPA lysis buffer (500 µl/well) containing 1% protease inhibitor cocktail. The effect of miR-21 upregulation on Noxa protein expression levels was detected by western blotting, following the above-mentioned procedure.
Statistical analysis. Statistical analysis was performed using SPSS 13.0 statistical software (SPSS, Inc., Chicago, IL, USA). The normality data are expressed as means ± standard deviation and the non-normal data are expressed as medians. Data were compared between two or multiple groups using Student's t-test and one-way analysis of variance, respectively. The non-parametric test was performed by Mann-Whitney rank-sum test and χ 2 test. P<0.05 was considered to indicate a statistically significant difference.
Results
Increased expression levels of miR-21 in gastric cancer tissue are associated with the clinical features of gastric cancer.
As presented in Fig. 1 Fig. 2 , RT-qPCR detection Table I . Association between miR-21 expression and pathological characteristics of patients with gastric cancer. demonstrated that the mRNA level of Noxa in tumor tissue was significantly lower than that of the adjacent non-tumor tissue samples (P<0.05). Consistent with the RT-qPCR results, the western blot analysis indicated that the Noxa protein expression level in the tumor tissue was decreased (Fig. 3) . The correlation analysis (Fig. 4 ) demonstrated that the mRNA expression level of Noxa in the gastric cancer tissue samples was inversely proportional to the level of miR-21 mRNA expression (r=-0.782; P<0.05).
Upregulation of miR-21 promotes growth of SGC-7901 cells.
As presented in Fig. 5 , MTT analysis indicated that following upregulation of miR-21, the rate of proliferation of SGC-7901 cells was significantly increased. Following culture for 12 and 48 h, the OD value of SGC-7901 cells following upregulation of miR-21 was significantly higher than that of the non-transfected (control) and miR-NC-transfected SGC-7901 cells (P<0.05). Cell cycle analysis revealed that following transfection of the miR-21 mimic, the ratio of G 0 /G 1 of SGC-7901 cells decreased, while the proportion of cells in the S phase increased, indicating active DNA synthesis in the cells (Fig. 6 ). (Fig. 10) . Noxa is a member of the Bcl-2 family, which is located in the mitochondrial membrane and exerts pro-apoptotic effects (20, 21) . Its mechanism of pro-apoptosis is associated with the mitochondrial cytochrome c signaling pathway. Noxa increases the permeability of the mitochondrial membrane, promoting the release of cytochrome c (9, 10) . It is a downstream gene of p53 and when cells are damaged following stimulation, p53 binds with the upstream promoter sequence of Noxa to enhance expression levels. Thus, the pro-apoptotic effects of Noxa are dependent on p53 (22) (23) (24) . In tumor cells, Noxa expression levels decrease, which may affect tumor cell apoptosis and reduce the effect of therapeutic agents (25) . For example, Kuwahara et al (26) found that decreased Noxa expression levels may result in decreased sensitivity to chemotherapeutic agents in malignant rhabdoid tumor. Ehrhardt et al (27) observed that following p53 and Noxa gene knockout, apoptosis of acute lymphoblastic leukemia, induced by conventional cytotoxic therapeutic agents combined with betulinic acid, decreased. Consistent with these previous findings, decreased expression levels of Noxa were observed in gastric cancer tissue samples in the present study. In addition, Noxa expression levels in gastric cancer patients were observed to be negatively correlated with the miR-21 expression level. The bioinformatics software and dual luciferase reporter enzymes indicated that Noxa is the target gene of miR-21 and upregulation of miR-21 in SGC-7901 cells reduced the Noxa expression levels. Therefore, miR-21 and Noxa may serve as targets for the treatment of gastric cancer. However, the present study did not clarify the effect of variations in the expression level of Noxa on the gastric cancer cells, which requires further investigation.
Increased expression levels of miR-
In conclusion, miR-21 affects the proliferation, invasion and migration of gastric cancer cells via Noxa. Increased expression levels of miR-21 and decreased expression levels of Noxa decreases apoptosis of tumor cells and results in a poor prognosis for gastric cancer patients.
